Citizen Petition Requesting Federal Preemption of Certain State and Local Standards Affecting Blood, Blood Components, and Blood Derivatives; Request for Information; Reopening of Comment Period

摘要

The Food and Drug Administration (FDA) is reopening the comment period for the citizen petition filed on behalf of the American Blood Resources Association, American National Red Cross, American Association of Blood Banks, and Council of Community Blood Centers. The petition requests Federal preemption of State and local regulations on donor suitability, testing, and labeling of blood, blood components, and blood derivatives. FDA is taking this action in response to requests to allow additional time for public comment.